GSK
806 hedge funds and large institutions have $9.66B invested in GSK in 2023 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 352 increasing their positions, 219 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 811 → 806 (-5)
4% less capital invested
Capital invested by funds: $10B → $9.66B (-$374M)
19% less funds holding in top 10
Funds holding in top 10: 16 → 13 (-3)
Holders
806
Holding in Top 10
13
Calls
$269M
Puts
$167M
Top Buyers
| 1 | +$217M | |
| 2 | +$170M | |
| 3 | +$56M | |
| 4 |
Holocene Advisors
New York
|
+$42.1M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$30.2M |
Top Sellers
| 1 | -$226M | |
| 2 | -$142M | |
| 3 | -$121M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$114M |
| 5 |
Renaissance Technologies
New York
|
-$75M |